Oct 16, 2020· Comment from American Academy of Pediatrics· FDA-2020-N-1898-0033
Please accept the attached comments on behalf of the American Academy of Pediatrics for consideration by the Vaccines and Related Biological Products Advisory Committee for their October 22 meeting. If you have any questions about the content of the comments or would like further information please contact us at the email address listed below.